Medical device maker Medtronic plcMDT recently announced the receipt of FDA approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for the treatment ...

Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.

Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...

“With PLATINIUM we are definitively entering a new era for ICD and CRT-D devices. PLATINIUM’s unsurpassed longevity 1 will benefit all patients, both those who, thanks to the efforts of the medical ...

LONDON, LivaNova PLC a market-leading medical technology company, announced today the launch of PLATINIUM, its next-generation range of implantable cardiac defibrillators (ICDs) and cardiac ...

“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...

NEW YORK/CHICAGO, June 23 (Reuters) - Early intervention with Boston Scientific Corp's implantable devices, called cardiac resynchronization therapy, can slow the progression of heart failure, ...

RMH electrophysiologist Robert VerNooy, MD, has successfully implanted a new type of heart pacing device that helps doctors better treat patients diagnosed with heart failure. He is the first ...

CHICAGO, IL — Almost nine in 10 patients implanted with defibrillators who were also eligible for cardiac resynchronization therapy (CRT) actually did receive the pacing therapy in a US nationwide ...

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart ...

March 6, 2009 (Washington, DC) — In a national registry for patients with implantable cardioverter-defibrillators (ICDs), among those also eligible for cardiac resynchronization therapy (CRT), ...

ABBOTT PARK, Ill., Jan. 3, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for the Quadra ...